83 related articles for article (PubMed ID: 7724208)
1. [Significance of recombinant adenoviruses in experimental gene therapy].
Adám E; Nász I
Orv Hetil; 1995 Apr; 136(15):755-61. PubMed ID: 7724208
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adenovirus vectors for gene therapy and clinical trials.
Nász I; Adám E
Acta Microbiol Immunol Hung; 2001; 48(3-4):323-48. PubMed ID: 11791337
[TBL] [Abstract][Full Text] [Related]
4. Alternate adenovirus type-pairs for a possible circumvention of host immune response to recombinant adenovirus vectors.
Nász I; Adám E; Lengyel A
Acta Microbiol Immunol Hung; 2001; 48(2):143-6. PubMed ID: 11233691
[TBL] [Abstract][Full Text] [Related]
5. [Somatic gene therapy of mucoviscidosis using recombinant adenovirus: the start of a long course].
Rochat T
Schweiz Med Wochenschr; 1997 Feb; 127(5):148-57. PubMed ID: 9064758
[TBL] [Abstract][Full Text] [Related]
6. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
7. Intertype specific epitopes on the hexons of adenovirus types 1, 2, 5 and 6.
Adám E; Nász I; Lengyel A
Acta Microbiol Immunol Hung; 1996; 43(1):75-82. PubMed ID: 8806946
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
10. [Effects of gene therapy with replication-defective adenovirus ericlosing Egr-1 promoter and Smad7 cDNA on irradiation-induced pulmonary fibrosis: experiment with mice].
Wang L; Feng Y; Fu XL; Cai XW
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2847-52. PubMed ID: 17200022
[TBL] [Abstract][Full Text] [Related]
11. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
13. Antigenic homogeneity among the adenovirus hexon types of subgenus C.
Adám E; Nász I; Lengyel A
Arch Virol; 1995; 140(7):1297-301. PubMed ID: 7646361
[TBL] [Abstract][Full Text] [Related]
14. The composed antigenic structure of the adenovirus hexon protein.
Nász I
Virologie; 1988; 39(4):267-80. PubMed ID: 2464233
[TBL] [Abstract][Full Text] [Related]
15. In vivo adenovirus-mediated gene transfer for Parkinson's disease.
Horellou P; Bilang-Bleuel A; Mallet J
Neurobiol Dis; 1997; 4(3-4):280-7. PubMed ID: 9361305
[TBL] [Abstract][Full Text] [Related]
16. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
Harvey BG; Hackett NR; Ely S; Crystal RG
Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus dodecahedron, a new vector for human gene transfer.
Fender P; Ruigrok RW; Gout E; Buffet S; Chroboczek J
Nat Biotechnol; 1997 Jan; 15(1):52-6. PubMed ID: 9035106
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
Zabner J; Wadsworth SC; Smith AE; Welsh MJ
Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
[TBL] [Abstract][Full Text] [Related]
19. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver.
Kuriyama S; Tominaga K; Kikukawa M; Nakatani T; Tsujinoue H; Yamazaki M; Nagao S; Toyokawa Y; Mitoro A; Fukui H
Anticancer Res; 1998; 18(4A):2345-51. PubMed ID: 9703877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
